These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26434663)

  • 41. Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children.
    Lell B; Luckner D; Ndjavé M; Scott T; Kremsner PG
    Lancet; 1998 Mar; 351(9104):709-13. PubMed ID: 9504515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The mosquito transmission of malaria: the effects of atovaquone-proguanil (Malarone) and chloroquine.
    Enosse S; Butcher GA; Margos G; Mendoza J; Sinden RE; Høgh B
    Trans R Soc Trop Med Hyg; 2000; 94(1):77-82. PubMed ID: 10748906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro.
    Thapar MM; Gupta S; Spindler C; Wernsdorfer WH; Björkman A
    Trans R Soc Trop Med Hyg; 2003; 97(3):331-7. PubMed ID: 15228254
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atovaquone and proguanil for Plasmodium falciparum malaria.
    Radloff PD; Philipps J; Nkeyi M; Hutchinson D; Kremsner PG
    Lancet; 1996 Jun; 347(9014):1511-4. PubMed ID: 8684102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Case of Recrudescence Plasmodium falciparum Malaria Treated with Atovaquone-Proguanil.
    Kaman A; Tanır G; Akkaya B; Bayhan Gİ; Gayretli Aydın ZG; Aydın Teke T
    Turkiye Parazitol Derg; 2018 Sep; 42(3):233-236. PubMed ID: 30072357
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atovaquone-proguanil for prophylaxis and treatment of malaria.
    Marra F; Salzman JR; Ensom MH
    Ann Pharmacother; 2003 Sep; 37(9):1266-75. PubMed ID: 12921511
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax.
    Mavrogordato A; Lever AM
    J Infect; 2012 Sep; 65(3):269-74. PubMed ID: 22609735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.
    Musset L; Bouchaud O; Matheron S; Massias L; Le Bras J
    Microbes Infect; 2006 Sep; 8(11):2599-604. PubMed ID: 16962361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety of atovaquone-proguanil during pregnancy.
    Mayer RC; Tan KR; Gutman JR
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30544231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. WITHDRAWN: Drugs for preventing malaria in travellers.
    Jacquerioz FA; Croft AM
    Cochrane Database Syst Rev; 2015 Oct; (10):CD006491. PubMed ID: 26436859
    [No Abstract]   [Full Text] [Related]  

  • 51. A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia.
    Sukwa TY; Mulenga M; Chisdaka N; Roskell NS; Scott TR
    Am J Trop Med Hyg; 1999 Apr; 60(4):521-5. PubMed ID: 10348223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atovaquone-proguanil for recrudescent Plasmodium falciparum in Vietnam.
    Giao PT; De Vries PJ; Hung LQ; Binh TQ; Nam NV; Kager PA
    Ann Trop Med Parasitol; 2003 Sep; 97(6):575-80. PubMed ID: 14511555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Malaria treatment with atovaquone-proguanil in malaria-immune adults: implications for malaria intervention trials and for pre-exposure prophylaxis of malaria.
    Polhemus ME; Remich S; Ogutu B; Waitumbi J; Lievens M; Ballou WR; Heppner DG
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1493-5. PubMed ID: 18268090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasmodium falciparum malaria occurring four years after leaving an endemic area.
    Vantomme B; Van Acker J; Rogge S; Ommeslag D; Donck J; Callens S
    Acta Clin Belg; 2016 Apr; 71(2):111-3. PubMed ID: 26312505
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phototoxic reaction associated with Malarone (atovaquone/proguanil) antimalarial prophylaxis.
    Amelot A; Dupouy-Camet J; Jeanmougin M
    J Dermatol; 2014 Apr; 41(4):346-8. PubMed ID: 24612343
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of proguanil in malaria patients treated with proguanil plus atovaquone.
    Edstein MD; Looareesuwan S; Viravan C; Kyle DE
    Southeast Asian J Trop Med Public Health; 1996 Jun; 27(2):216-20. PubMed ID: 9279980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasmodium falciparum malaria and atovaquone-proguanil treatment failure.
    Durand R; Prendki V; Cailhol J; Hubert V; Ralaimazava P; Massias L; Bouchaud O; Le Bras J
    Emerg Infect Dis; 2008 Feb; 14(2):320-2. PubMed ID: 18258131
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current status and replies to frequently posed questions on atovaquone plus proguanil (Malarone) for the prevention of malaria.
    Kain KC
    BioDrugs; 2003; 17 Suppl 1():23-8. PubMed ID: 12785875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A statistical analysis of the antimalarial activity of proguanil and cycloguanil in human volunteers.
    Yeo AE; Edstein MD; Shanks GD; Rieckmann KH
    Ann Trop Med Parasitol; 1994 Dec; 88(6):587-94. PubMed ID: 7893172
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lack of a pharmacokinetic interaction between atovaquone and proguanil.
    Gillotin C; Mamet JP; Veronese L
    Eur J Clin Pharmacol; 1999 Jun; 55(4):311-5. PubMed ID: 10424325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.